ArticleGeneral thoracic and cardiovascular surgery cases2026
Minimally invasive coronary artery bypass grafting via a left lateral mini-thoracotomy in severe hemophilia A: a case report.
Article in General thoracic and cardiovascular surgery cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLife expectancy in patients with hemophilia A has increased owing to advances in factor VIII replacement, and the prevalence of age-related comorbidities such as coronary artery disease (CAD) is rising. However, coronary revascularization in severe hemophilia A remains challenging because both antithrombotic therapy and surgery can precipitate serious bleeding. We report a case of minimally invasive coronary artery bypass grafting (MICS-CABG) in a patient with severe hemophilia A, focusing on perioperative factor VIII management. CASE PRESENTATION: A 50-year-old man (height 167 cm, weight 81 kg) with severe hemophilia A (baseline factor VIII activity < 1%) was followed at our institution. His bleeding history included mucosal and gastrointestinal hemorrhage requiring on-demand factor VIII replacement. He presented with exertional chest pain, and coronary angiography revealed single-vessel CAD involving the left anterior descending (LAD) and diagonal territory. Surgical revascularization was selected to avoid the need for long-term dual antiplatelet therapy after percutaneous coronary intervention involving an indwelling drug-eluting stent. Preoperative echocardiography showed preserved left ventricular function. MICS-CABG via a left lateral mini-thoracotomy was performed, with the left internal thoracic artery (LITA) used as a sequential graft to the diagonal branch and LAD. Perioperative hemostasis was managed in collaboration with the hematologists using recombinant factor VIII. A preoperative bolus was followed by continuous infusion and scheduled dose adjustments based on serial factor VIII activity measurements. Total operative time was 5 h 32 min, and intraoperative blood loss was 407 mL without transfusion. No major bleeding or thrombotic events occurred. Postoperative coronary computed tomography confirmed excellent graft patency, and the patient was discharged without complications.
conclusionsEven in severe hemophilia A, MICS-CABG can be performed safely when combined with meticulous perioperative factor VIII replacement and activity monitoring. A minimally invasive surgical approach may help limit blood loss and transfusion requirements, and represents a useful revascularization option for selected patients with hemophilia and CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.